Welcome to our dedicated page for Healthwarehouse news (Ticker: HEWA), a resource for investors and traders seeking the latest updates and insights on Healthwarehouse stock.
HealthWarehouse.com, Inc. (OTCQB: HEWA) is a healthcare e‑commerce and technology company that regularly publishes detailed financial and operational updates. As an NABP Approved Digital Pharmacy based in Florence, Kentucky, HealthWarehouse.com reports on its performance in selling and delivering prescription and over‑the‑counter medications to customers in all 50 states, serving both direct‑to‑consumer and partner services (B2B) channels.
On this page, readers can follow HEWA news that covers quarterly and annual results, trends in prescription and over‑the‑counter sales, and management’s commentary on business drivers. Company releases discuss net sales, gross profit, operating expenses, net income or loss, and non‑GAAP measures such as EBITDA and Adjusted EBITDA, along with explanations of how product mix and partner services margins affect these figures.
HealthWarehouse.com’s news flow often highlights the impact of GLP‑1 medications on its results, including brand and compounded GLP‑1 prescriptions fulfilled through its partner services and direct‑to‑consumer businesses. The company also reports on technology initiatives, such as new pharmacy software and a proprietary e‑commerce platform, and how these investments relate to patient experience, operational efficiency, and scalability.
Investors and observers can use this news feed to review management’s discussion of topics like cold‑chain shipping capabilities, changes in over‑the‑counter marketplace sales, and the evolution of its B2B partner services pipeline. For ongoing insight into HealthWarehouse.com’s operating trends, financial performance, and strategic focus areas, this HEWA news page aggregates the company’s latest publicly released updates.
HealthWarehouse.com, Inc. (OTC:HEWA) reported a net income of $641,326 and net sales of $17,178,985 for 2020, marking a net income turnaround from a loss of $99,400 in 2019. Adjusted EBITDA was $593,744, down from $712,312 the previous year. The company saw a 9% rise in total net sales from 2019, driven by a 25% increase in over-the-counter sales amid COVID-19 demand. Operating expenses rose 12%, primarily due to staffing and variable costs. HealthWarehouse.com is preparing to launch new pharmacy software in Q3 2021, aiming to enhance operational efficiency.